| Development of some mammalian cell based models to screen potent leads that might inhibit viral infection | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences | 2020 | |
| Identification and development of potential antiviral drug molecules against SARS-CoV-2 | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences | 2020 | |
| Neutralizing Peptide Antibody Designed for Human Complement Fragment 5a (hC5a) | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences | 2020 | |
| Rational Design of Broad-Spectrum Antiviral Peptides Targeting SARS-CoV2-Spike Protein | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences | 2020 | |
| Engineering of epitope peptides from structural and non-structural proteins of coronavirus 2019-nCoV on Virus-Like particle (VLPs) to develop vaccine candidates | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences | 2020 | |
| Working on mRNA/peptide-based vaccine for SARS-Cov-2 | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences | 2020 | |
| Identifying potential drug targets in the structural proteins of SARS-Cov-2 | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences | 2020 | |
| Virtual Screening and in vitro validation of SARS CoV-II Main Protease inhibitors | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences | 2020 | |
| Small molecules screening on spike protein of Covid19 | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences | 2020 | |
| Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences | 2020 | |